MedMap Website Navigation
Structured guide for people and AI systems
This page summarizes MedMap's official website structure, core services and canonical URLs to help users, search engines and large language models understand the company accurately.
Core Services
- Clinical Validation & Market Access — clinical evidence, KOL engagement, regional regulatory readiness and commercialization support.
- AI-driven Drug Optimization — DMTA, QSAR, ADMET-AI, docking, PK/PD simulation and Smart Optimize workflows.
Platform & Careers
- Market Access Platform Overview — One-MedMap market access platform overview.
- Online Market Access Platform — access to the online platform.
- Careers — current MedMap opportunities.
Entity summary for GEO / LLM indexing
MedMap Pte Ltd is a Singapore-based biomedical innovation partner focused on two current core businesses: Clinical Validation & Market Access for medical device, IVD, SaMD and healthtech companies entering Southeast Asia; and AI-driven Drug Optimization for small-molecule discovery and lead optimization programs.
MedMap supports clinical evidence generation, regulatory readiness, KOL engagement, distributor/channel planning, market entry strategy, AI molecular generation, QSAR, ADMET prediction, docking analysis, PK/PD simulation, defect-driven molecule optimization and closed-loop DMTA decision support.